Shopping Cart
Remove All
Your shopping cart is currently empty
Fianlimab (REGN3767) is a monoclonal antibody targeting LAG-3 (Lymphocyte Activation Gene 3) in humans, exhibiting antitumor activity. It can be used to study melanoma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $197 | - | In Stock | |
| 5 mg | $516 | - | In Stock | |
| 10 mg | $828 | - | In Stock | |
| 25 mg | $1,230 | - | In Stock | |
| 50 mg | $1,650 | - | In Stock |
| Description | Fianlimab (REGN3767) is a monoclonal antibody targeting LAG-3 (Lymphocyte Activation Gene 3) in humans, exhibiting antitumor activity. It can be used to study melanoma. |
| Synonyms | REGN3767, REGN 3767 |
| Reactivity | Human |
| Verified Activity | Immobilized Human LAG-3 Protein (His) at 2 μg/mL (30 μL/well) can bind Fianlimab. The EC50 is 0.03073 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | LAG3/CD223 |
| Molecular Weight | 146.46 kDa |
| Cas No. | 2126132-98-5 |
| Isotype | Human IgG4SP kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.